|ZFIN ID: ZDB-PUB-191012-1|
Zebrafish Models of Diamond-Blackfan Anemia: A Tool for Understanding the Disease Pathogenesis and Drug Discovery
Uechi, T., Kenmochi, N.
|Source:||Pharmaceuticals (Basel, Switzerland) 12(4): (Review)|
|Registered Authors:||Kenmochi, Naoya, Uechi, Tamayo|
|Keywords:||Diamond-Blackfan anemia, disease model, drug candidate, ribosome, zebrafish|
|PubMed:||31600948 Full text @ Pharmaceuticals (Basel)|
Uechi, T., Kenmochi, N. (2019) Zebrafish Models of Diamond-Blackfan Anemia: A Tool for Understanding the Disease Pathogenesis and Drug Discovery. Pharmaceuticals (Basel, Switzerland). 12(4).
ABSTRACTDiamond-Blackfan anemia (DBA) is a rare bone marrow failure syndrome characterized by red blood cell aplasia. Currently, mutations in 19 ribosomal protein genes have been identified in patients. However, the pathogenic mechanism of DBA remains unknown. Recently, several DBA models were generated in zebrafish (Danio rerio) to elucidate the molecular pathogenesis of disease and to explore novel treatments. Zebrafish have strong advantages in drug discovery due to their rapid development and transparency during embryogenesis and their applicability to chemical screens. Together with mice, zebrafish have now become a powerful tool for studying disease mechanisms and drug discovery. In this review, we introduce recent advances in DBA drug development and discuss the usefulness of zebrafish as a disease model.
ADDITIONAL INFORMATION No data available